Inaba Taro
Fondateur chez Remiges Ventures Inc.
Postes actifs de Inaba Taro
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Remiges Ventures Inc.
 Remiges Ventures Inc. Investment ManagersFinance Remiges Ventures Inc. (Remiges Ventures) is a venture capital firm founded in 2014 by Taro Inaba. It is headquartered in Cambridge, United States. | Fondateur | 01/06/2014 | - |
| Private Equity Investor | 01/06/2014 | - | |
Capacity Bio, Inc.
 Capacity Bio, Inc. BiotechnologyHealth Technology Capacity Bio, Inc. is a biotech company based in an undisclosed location. The American company is focused on developing a first-in-class mitophagy therapeutic platform and an advanced analytical toolkit to characterize mitochondria. The company was founded by Amy Wang, Stan Louie, and Kathy Rodgers, and the CEO is Kenneth Nicholas Horne. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Inaba Taro
Anciens postes connus de Inaba Taro
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MITSUI & CO., LTD. | Corporate Officer/Principal | 01/10/2008 | 01/05/2014 |
Formation de Inaba Taro
| European University at Saint Petersburg | Masters Business Admin |
| Kyoto University | Undergraduate Degree |
Statistiques
Internationale
| Japon | 3 |
| Etats-Unis | 3 |
| Russie | 2 |
Opérationnelle
| Corporate Officer/Principal | 1 |
| Founder | 1 |
| Private Equity Investor | 1 |
Sectorielle
| Consumer Services | 3 |
| Process Industries | 2 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MITSUI & CO., LTD. | Process Industries |
| Entreprise privées | 2 |
|---|---|
Remiges Ventures Inc.
Remiges Ventures Inc. Investment ManagersFinance Remiges Ventures Inc. (Remiges Ventures) is a venture capital firm founded in 2014 by Taro Inaba. It is headquartered in Cambridge, United States. | Finance |
Capacity Bio, Inc.
Capacity Bio, Inc. BiotechnologyHealth Technology Capacity Bio, Inc. is a biotech company based in an undisclosed location. The American company is focused on developing a first-in-class mitophagy therapeutic platform and an advanced analytical toolkit to characterize mitochondria. The company was founded by Amy Wang, Stan Louie, and Kathy Rodgers, and the CEO is Kenneth Nicholas Horne. | Health Technology |
- Bourse
- Insiders
- Inaba Taro
- Expérience
